Regulatory and safety status: Emideltide is not approved for use in humans and is currently pending FDA review
Refusal to share this information or other critical safety details should raise concerns
Not perfect, but far less waste than 4mg unused
To move Epitalon from experimental to evidence-based, several developments are essential: Randomized, double-blind, placebo-controlled clinical trials, ideally targeting specific endpoints (sleep, immune aging, telomere attrition) Toxicology and long-term safety studies, including exploration of stereoisomer effects and off-target consequences Validated delivery systems (e.g., dendrimer-conjugates, transdermal patches) that make real-world use feasible Pharmacodynamic biomarkers, to identify responders and track efficacy objectively over time Epitalon is not snake oil, but its also not a magic bullet
We accept credit & debit cards (including Apple Pay and Google Pay), SEPA / bank transfer, and cryptocurrency
M.van de HaarH